| Literature DB >> 27263607 |
Fatih Demircioğlu1, Şule Çağlayan Sözmen, Şebnem Yılmaz, Hale Ören, Nur Arslan, Abdullah Kumral, Erdener Özer, Gülersu İrken.
Abstract
A 33 weeks' gestation, a baby with rhesus hemolytic disease (RHD), who had received intrauterine transfusions twice, developed cholestatic hepatic disease and late hyporegenerative anemia. Her serum ferritin and bilirubin levels increased to 8842 ng/ml and 17.9 mg/dl, respectively. Liver biopsy showed cholestasis and severe iron overload. Treatment with recombinant erythropoietin (rHuEPO) decreased the transfusion need, and intravenous deferoxamine resulted in a marked decreased in serum ferritin levels and normalization of liver function. In patients who have undergone intrauterine transfusions due to RHD, hyperferritinemia and late hyporegenerative anemia should be kept in mind. Chelation therapy in cases with symptomatic hyperferritinemia and rHuEPO treatment in cases with severe hyporegenerative anemia should be considered.Entities:
Year: 2010 PMID: 27263607 DOI: 10.5152/tjh.2010.30
Source DB: PubMed Journal: Turk J Haematol ISSN: 1300-7777 Impact factor: 1.831